Published in Women's Health Weekly, January 6th, 1997
The clinical trial, to be conducted at the University of Rochester Medical Center, Rochester, New York, will assess the safety and immunogenicity of the HPV vaccine candidate. HPVs are responsible for the development of genital warts and cervical cancer. There are currently no vaccines to prevent these common sexually transmitted diseases (STDs) that affect 24 to 40 million men and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly